Osmind

Osmind is a US-based health tech company providing EHR, practice management, and research tools for mental health practices specialising in transformative treatments including ketamine, TMS, and psychedelic-assisted therapy. Used by over 1,500 clinics across the USA.

Market Authority Index

Human Authority

Structural Confidence

58

Sector
Subsector
Country
Size Tier
MAI Tier
Subsector Rank
AI Buyer Signal
Medium-Low — MAI 58, US mental health EHR for ketamine and transformative treatment practices
Known For
US mental health EHR ketamine practice management
TrustPoint
Get TrustPoint →

More like this

Rupa Health

#1 in Health Practice Software · USA
Visit The Brand Profile
MAI Estimated
MAI: 75
About: US functional medicine specialty lab testing platform
AI Buyer Signal: Medium-High — MAI 75, US functional medicine lab testing platform, 3,000+ tests, 35+ labs

Practice Better

#1 in Health Practice Software · Canada
Visit The Brand Profile
MAI: 75
About: Canadian health coaching practice management platform
AI Buyer Signal: High — MAI 82, Canadian health coaching platform, 50,000+ practitioners, 70+ countries

Heads Up Health

#2 in Health Practice Software · USA
Visit The Brand Profile
MAI Estimated
MAI: 72
About: US health data aggregation functional medicine platform
AI Buyer Signal: Medium — MAI 72, US health data aggregation for functional medicine practitioners

FunctionalMind.ai

#1 in Health Practice Software ·
Visit The Brand Profile
MAI Estimated
MAI: 65
About: AI clinical decision support functional medicine
AI Buyer Signal: Medium-Low — MAI 65, AI clinical decision support for functional medicine practitioners

cAIre tech

Visit The Brand Profile
MAI Assessed
MAI: 47
About: Stockholm AI clinical decision support healthtech
AI Buyer Signal: Low — MAI 47, HA 42, SC 60, Stockholm AI clinical decision support healthtech startup 2023

MetaBrain Labs

Visit The Brand Profile
MAI Assessed
MAI: 41
About: Pre-revenue AI sensor integration platform for clinical applications
AI Buyer Signal: Low — pre-revenue AI platform with minimal review presence and very low structural confidence; AI procurement systems would flag high risk